5.60
+0.05
+(0.90%)
At close: 4:00:00 PM EDT
5.58
-0.02
(-0.36%)
After hours: 6:43:09 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
103,916
103,916
93,866
66,331
93,854
Operating Income
-103,916
-103,916
-93,866
-66,331
-93,854
Net Non Operating Interest Income Expense
9,275
9,275
4,664
1,495
-359
Other Income Expense
-14,038
-14,038
-6,530
8,040
20
Pretax Income
-108,679
-108,679
-95,732
-56,796
-94,193
Tax Provision
--
--
--
--
-1,157
Net Income Common Stockholders
-108,679
-108,679
-95,732
-56,796
-93,036
Diluted NI Available to Com Stockholders
-108,679
-108,679
-95,732
-56,796
-93,036
Basic EPS
-1.54
--
-2.44
-1.84
-3.45
Diluted EPS
-1.54
--
-2.44
-1.84
-3.45
Basic Average Shares
70,461.07
--
39,157.42
30,857.46
27,377.08
Diluted Average Shares
70,461.07
--
39,157.42
30,857.46
27,377.08
Total Operating Income as Reported
-103,916
-103,916
-93,866
-66,331
-93,854
Total Expenses
103,916
103,916
93,866
66,331
93,854
Net Income from Continuing & Discontinued Operation
-108,679
-108,679
-95,732
-56,796
-93,036
Normalized Income
-94,641
-94,641
-89,253
-64,834
-92,951.06
Interest Income
11,558
11,558
5,584
--
--
Interest Expense
2,283
2,283
920
--
359
Net Interest Income
9,275
9,275
4,664
1,495
-359
EBIT
-106,396
-106,396
-94,812
-66,331
-93,854
EBITDA
-105,869
-105,869
-91,650
-63,151
-91,238
Reconciled Depreciation
527
527
3,162
3,180
2,616
Net Income from Continuing Operation Net Minority Interest
-108,679
-108,679
-95,732
-56,796
-93,036
Total Unusual Items Excluding Goodwill
-14,038
-14,038
-6,479
8,038
-86
Total Unusual Items
-14,038
-14,038
-6,479
8,038
-86
Normalized EBITDA
-91,831
-91,831
-85,171
-71,189
-91,152
Tax Rate for Calcs
--
--
--
--
0
Tax Effect of Unusual Items
--
--
--
--
-1.06
12/31/2021 - 11/15/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYBN Cybin Inc.
7.70
0.00%
ATAI Atai Life Sciences N.V.
1.3900
+0.72%
CYBN.NE Cybin Inc.
10.77
+15.31%
GHRS GH Research PLC
8.99
-1.10%
CMND Clearmind Medicine Inc.
0.9200
-0.35%
DRUG Bright Minds Biosciences Inc.
32.41
-1.04%
CRSP CRISPR Therapeutics AG
38.95
+0.36%
BEAM Beam Therapeutics Inc.
17.28
+1.65%
NTLA Intellia Therapeutics, Inc.
7.36
-1.87%
ABSI Absci Corporation
3.1200
+0.97%